Our team has been hard at work parsing out the most important trends and generating meaningful insights across our customer segments for your company’s business needs. Here’s a quick overview of all of the reports and insights we’ve released this summer, which you can dive into here after signing into our client portal.
For further insights and musings on the oncology sector, please also check out our latest articles at https://www.hmpmarketaccessinsights.com/insights. From articles on the Enhancing Oncology Model and IDN pharmacy performance metrics to payer pathways, we are sure to cover a topic that piques your interest!
As manufacturers prepare for Medicare drug price negotiations, a critical question emerges: How will your provider engagement strategy evolve when Maximum Fair Prices (MFP) take effect in 2026?
Emma BijesseAt HMP Market Access Insights, we’re lucky to have a team of experts dedicated to uncovering meaningful insights in the oncology space. One of those experts is Dan, whose work is shaping how we approach community oncology research.
Daniel BuchenbergerAs IDNs face increasing complexity in oncology management, having a strategic approach backed by actionable insights is critical. Our dataset doesn’t just offer data—it equips your teams with the tools to anticipate challenges and seize opportunities.
Emma Bijesse